Merck & Co. SWOT & PESTLE Analysis
COMPANY PROFILE -Merck & Co.
Business Sector :Pharmaceuticals
Operating Geography :United States, North America, Global
About Merck & Co. :
Merck & Co., Inc., headquartered in Kenilworth, New Jersey, is an American global pharmaceutical business. Merck & Co. has its roots in Merck Group, a former German parent firm founded by the Merck family in 1668 when Friedrich Jacob Merck bought a medicine business in Darmstadt. Merck & Co. was founded in 1891 as a subsidiary of Merck & Co. in the United States. The company remains at the forefront of research to prevent and treat diseases that threaten people and animals, such as cancer, infectious diseases like HIV and Ebola, and emerging animal diseases. The company works with clients and operates in more than 140 countries to supply innovative health solutions through prescription medications, vaccines, biological therapies, and animal health products. It also shows its dedication to expanding access to health care by implementing far-reaching policies, programmes, and collaborations. Merck announced in June 2022 that the FDA had approved an expanded indication for VAXNEUVANCETM (Pneumococcal 15-valent Conjugate Vaccine) (pronounced VAKS-noo-vans) to include children aged 6 weeks to 17 years.
Merck & Co.'s Unique Selling Point or USP lies in it being the world's leading biopharmaceutical firm, with more than a century of experience creating for life and developing medicines and vaccines for some of the world's most difficult diseases. The mission statement of Merck & Co. reads, "We aspire to improve the health and wellness of people and animals worldwide and to expand access to our medicines and vaccines. All of our actions must be measured against our responsibility to those who use or need our products".
Merck & Co. Revenue :
$ 48,704 million – FY ending 31st December 2021
$ 47,994 million – FY ending 31st December 2020
Competitive Analysis of Merck & Co.
Strengths | Weaknesses |
1. Best management team in pharmaceutical industry 2. Market exclusivity because of global patent portfolios 3. Competitive positioning based on research and development 4. Animal Health Care division among top performers in the world | 1. Significant dependance on a few products 2. High dependance on patented products for high profitability |
Opportunities | Threats |
1. High growth in global pharmaceutical market 2. High growth in global biologics market 3. Growth opportunities from strategic acquisitions | 1. Negative events in animal health industry 2. Stiff competition for patent rights 3. Coronavirus pandemic slowing sales of other products |
Complete Report
USD 19.53
- Debit/Credit card
- PayPal

Detailed SWOT Analysis of Merck & Co.
Strength
1. Best management team in pharmaceutical industry: A report by the Wall Street Journal in 2021 judged Merck & Co. as one of the top 3 managed pharmaceutical companies in the world. The report judged companies on five dimensions, namely, customer satisfaction, financial strength, innovation, social responsibility, and employee engagement and development. Out of the five dimensions Merck has scored the highest in social responsibility. The company has also been named one of the best employers for diversity, women and fresh graduates in 2021 making it the 30th most fair companies in America, 87th best employer in America and 529th best employer in the world across industries.
2. Market exclusivity because of global patent portfolios: Merck & Co. has key patent protection in major developed economies like US, EU, Japan, and China. Patent protection is of material importance for marketing of products in these markets. Patents derive commercial exclusivity benefits even after their expiration through patents on novel processes, intermediaries, uses, compositions, and formulations based on the given product. Certain countries like United States, which have laws for increasing patent life, provide further additions to market exclusivity. Merck’s flagship patent is Keytruda, which is an anti-cancer therapy in development. The company claims Keytruda can treat more than 30 different types of cancers and is conducting further trials to increase its efficacy.
The remaining section under "Strength" is available only in the 'Complete Report' on purchase.
Weakness
This section is available only in the 'Complete Report' on purchase.
Opportunity
This section is available only in the 'Complete Report' on purchase.
Threat
This section is available only in the 'Complete Report' on purchase.
Complete Report
USD 19.53
- Debit/Credit card
- PayPal

TABLE OF CONTENTS
DELIVERY AND FORMAT
WHY CHOOSE US?



You may also be interested in other analyses of Merck & Co.:
-
Merck & Co. Porter's Five Forces Analysis -
Merck & Co. VRIO Analysis -
Merck & Co. Value Chain Analysis -
Merck & Co. Covid-19 Impact Analysis -
Merck & Co. BCG Analysis -
Merck & Co. Segmentation, Targeting and Positioning (STP) Analysis -
Merck & Co. Ansoff Matrix Analysis


Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.


Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.


Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.


Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.


Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.


Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.


Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.


Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.


Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.


Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.


Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.


Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.


Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.


Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.


Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.


Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.


Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.


Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.


Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
Check Out Analysis of Other Relevant Companies
References used in Merck & Co. SWOT & PESTLE Analysis Report
1. J&J, Lilly, Merck have best management in pharma, says report - https://www.biopharmadive.com/news/jj-lilly-merck-have-best-management-in-pharma-says-report/512416/
2. Annual Report - https://s21.q4cdn.com/488056881/files/doc_financials/2020/q4/4df43d8f-8b85-45da-92ef-7ad82f343c3b.pdf
3. Quarter 4 results - https://s21.q4cdn.com/488056881/files/doc_financials/2020/q4/4df43d8f-8b85-45da-92ef-7ad82f343c3b.pdf
4. Here’s where the Federal Reserve sees interest rates, the economy and inflation going - https://www.cnbc.com/2021/03/17/heres-where-the-federal-reserve-sees-interest-rates-the-economy-and-inflation-going-in-the-future.html
The detailed complete set of references are available on request in the 'Complete report' on purchase.
How to Reference This Page?
You can use the following in your reference section in order to give credit to the source. For different referencing styles and detailed guidelines, please click here.
Merck & Co. SWOT & PESTLE Analysis - SWOT & PESTLE.COM
SWOT & PESTLE.com (2023). Merck & Co. SWOT & PESTLE Analysis - SWOT & PESTLE.com. [online] Available at: https://www.swotandpestle.com/merck-co/ [Accessed 04 Feb, 2023].
In-text: (SWOT & PESTLE.com, 2023)
Copyrights and Disclaimer
Merck & Co. SWOT and PESTLE analysis has been conducted by Divyansh Kharadkar and reviewed by senior analysts from Barakaat Consulting.
Copyright of Merck & Co. SWOT and PESTLE Analysis is the property of Barakaat Consulting. Please refer to the Terms and Conditions and Disclaimer for usage guidelines.